Synthesis of a diversified combinatorial library of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives
General procedure for the synthesis
(m, 3H), 8.45 (s, 1H) ppm; 13C NMR (75 MHz, DMSO-d6):
of 1H-pyrazolo[1,2-b]phthalazine-5,10-dione derivatives
d = 61.9, 83.5, 123.5, 123.7, 127.1, 127.6, 129.0, 129.6,
130.2, 134.0, 134.8, 141.8, 147.9, 149.1, 153.7, 156.7,
A mixture of phthalimide/phthalic anhydride (1 mmol) and
hydrazine hydrate (1 mmol) was stirred in 5 cm3 water in
the presence of 70 mg PEG-SAC at 60 °C for 10 min, and
then aldehyde (1 mmol) and active methylene component
(1 mmol) were added and stirred for the required period of
time (TLC). After completion of the reaction, water was
removed under reduced pressure from the reaction mixture,
and acetone was added to it for the dissolution of crude
product. The acetone solution was filtered to remove the
catalyst. The solid was obtained upon concentrating the
acetone solution of the crude product extract. The product
thus appearing was collected by filtration, washed with
chilled aqueous ethanol, and finally recrystallized from
ethanol to obtain pure product.
166.8 ppm; IR (KBr): vꢀ = 1,683, 1,526, 1,349 cm-1
.
3-Amino-1-(4-fluorophenyl)-5,10-dioxo-5,10-dihydro-1H-
pyrazolo[1,2-b]phthalazine-2-carboxamide
(3c, C18H13FN4O3)
1H NMR (300 MHz, DMSO-d6): d = 6.36 (s, 2H), 6.40 (s,
1H), 7.09 (t, J = 8.7 Hz, 2H), 7.51–7.61 (m, 4H), 7.88–
8.22 (m, 4H) ppm; 13C NMR (75 MHz, DMSO-d6):
d = 61.8, 84.0, 115.2, 125.3, 126.9, 127.4, 128.9, 129.1,
130.1, 130.2, 133.7, 134.6, 135.5, 148.5, 153.2, 154.9,
166.7 ppm; IR (KBr): vꢀ = 1,684, 1,526, 1,343 cm-1
.
3-Amino-1-(4-chlorophenyl)-5,10-dioxo-5,10-dihydro-1H-
pyrazolo[1,2-b]phthalazine-2-carboxamide
(3d, C18H13ClN4O3)
1H NMR (300 MHz, DMSO-d6): d = 6.35 (s, 1H), 6.42 (s,
2H), 7.33 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 4.2 Hz, 2H),
7.63 (s, 2H), 7.88–8.22 (m, 4H) ppm; 13C NMR (75 MHz,
DMSO-d6): d = 61.6, 83.7, 126.7, 127.2, 128.1, 128.7,
129.0, 129.8, 132.6, 133.6, 134.4, 138.3, 148.4, 153.1, 156.2,
3-Amino-1-(furan-2-yl)-5,10-dioxo-5,10-dihydro-1H-
pyrazolo[1,2-b]phthalazine-2-carbonitrile
(1h, C16H10N4O3)
1H NMR (300 MHz, DMSO-d6): d = 6.44 (dd, J1 = 3 Hz,
J2 = 1.8 Hz, 1H), 6.59 (d, J = 3.3 Hz, 1H), 7.61 (s, 1H),
7.95 (t, J = 4.5 Hz, 2H), 8.10 (t, J = 4.2 Hz, 3H), 8.20–
8.23 (m, 1H) ppm; 13C NMR (75 MHz, DMSO-d6):
d = 56.7, 58.4, 110.1, 111.1, 116.2, 127.1, 127.8, 128.9,
134.3, 135.3, 143.7, 143.8, 149.5, 151.5, 154.2, 157.0 ppm;
166.5 ppm; IR (KBr): vꢀ = 1,680, 1,522, 1,349 cm-1
.
3-Amino-1-(2,3-dichlorophenyl)-5,10-dioxo-5,10-dihydro-
1H-pyrazolo[1,2-b]phthalazine-2-carboxamide
(3e, C18H12Cl2N4O3)
IR (KBr): vꢀ = 2,203, 1,659, 1,385 cm-1
.
1H NMR (300 MHz, DMSO-d6): d = 6.19 (s, 2H), 6.59 (s,
1H), 7.36 (t, J = 7.8 Hz, 1H), 7.59 (dd, J1 = 7.8 Hz,
J2 = 1.2 Hz, 1H), 7.73–7.79 (m, 3H), 7.96 (d, J = 4.5 Hz,
2H), 8.05–8.29 (m, 2H) ppm; 13C NMR (75 MHz, DMSO-
d6): d = 62.4, 127.1, 127.6, 128.5, 128.7, 129.2, 130.7,
132.8, 134.2, 135.0, 138.4, 149.5, 153.4, 156.5, 166.7 ppm;
Ethyl 3-amino-5,10-dioxo-1-(m-tolyl)-5,10-dihydro-1H-
pyrazolo[1,2-b]phthalazine-2-carboxylate
(2g, C21H19N3O4)
1H NMR (300 MHz, DMSO-d6): d = 1.02 (t, J = 7.2 Hz,
3H), 2.24 (s, 3H), 3.93–3.96 (m, 2H), 6.01 (s, 1H), 7.02 (d,
J = 5.7 Hz, 1H), 7.11–7.18 (m, 4H), 7.93–8.27 (m, 5H) ppm;
13C NMR (75 MHz, DMSO-d6): d = 14.2, 21.0, 58.7, 63.3,
81.9, 124.5, 126.7, 127.3, 127.7, 127.8, 128.3, 128.8, 128.9,
133.6, 134.7, 137.0, 139.8, 149.7, 153.2, 156.8, 164.1 ppm;
IR (KBr): vꢀ = 1,684, 1,526, 1,349 cm-1
.
3-Amino-1-(4-bromophenyl)-5,10-dioxo-5,10-dihydro-1H-
pyrazolo[1,2-b]phthalazine-2-carboxamide
(3f, C18H13BrN4O3)
IR (KBr): vꢀ = 1,694, 1,663, 1,289 cm-1
.
1H NMR (300 MHz, DMSO-d6): d = 6.33 (s, 1H), 6.42 (s,
2H), 7.46 (s, 4H), 7.62 (s, 2H), 7.88–8.22 (m, 4H) ppm; 13
C
3-Amino-5,10-dioxo-1-phenyl-5,10-dihydro-1H-pyrazolo
[1,2-b]phthalazine-2-carboxamide (3a, C18H14N4O3)
1H NMR (300 MHz, DMSO-d6): d = 6.34–6.40 (m, 3H),
7.21–7.29 (m, 3H), 7.48 (d, J = 6.9 Hz, 2H), 7.60 (s, 2H),
7.88–7.91 (m, 2H), 8.02–8.05 (m, 1H), 8.20 (t, J = 1.8 Hz,
1H) ppm; 13C NMR (75 MHz, DMSO-d6): d = 62.3, 84.2,
126.7, 127.2, 127.7, 128.0, 128.2, 128.8, 129.0, 133.6,
134.4, 139.4, 148.2, 153.0, 156.2, 166.6 ppm; IR (KBr):
NMR (75 MHz, DMSO-d6): d = 61.7, 83.7, 121.2, 126.7,
127.2, 128.7, 129.0, 130.1, 131.1, 133.6, 134.4, 138.7,
148.4, 153.1, 156.2, 166.5 ppm; IR (KBr): vꢀ = 1,683,
1,524, 1,349 cm-1
.
3-Amino-5,10-dioxo-1-(m-tolyl)-5,10-dihydro-1H-pyrazolo-
[1,2-b]phthalazine-2-carboxamide (3g, C19H16N4O3)
1H NMR (300 MHz, DMSO-d6): d = 2.23 (s, 3H), 6.29 (s,
1H), 6.35 (s, 2H), 7.15 (t, J = 8.1 Hz, 1H), 7.29 (d,
vꢀ = 1,686, 1,500, 1,337 cm-1
.
J = 6.3 Hz, 2H), 7.60 (s, 2H), 7.83–8.06 (m, 5H) ppm; 13
C
3-Amino-1-(3-nitrophenyl)-5,10-dioxo-5,10-dihydro-1H-
pyrazolo[1,2-b]phthalazine-2-carboxamide
(3b, C18H13N5O5)
1H NMR (300 MHz, DMSO-d6): d = 6.49 (s, 3H), 7.57 (t,
J = 8.1 Hz, 1H), 7.68 (s, 2H), 7.88–7.94 (m, 3H), 8.02–8.22
NMR (75 MHz, DMSO-d6): d = 21.4, 62.7, 84.5, 125.5,
127.0, 127.5, 128.4, 129.0, 129.1, 129.3, 132.9, 133.9,
134.7, 137.7, 139.6, 148.5, 153.3, 156.5, 166.9 ppm; IR
(KBr): vꢀ = 1,687, 1,503, 1,335 cm-1
.
123